Jian-Sheng Kang (Jiansheng Kang)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 16

Top Venues

Signal transduction and targeted therapy

MedComm

Protein & cell

Neuroscience bulletin

First Affiliated Hospital of Zhengzhou University

Shanghai Institutes for Biological Sciences (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

First Affiliated Hospital of Zhengzhou University

China

Professor

Institute for Nutritional Sciences Shanghai Institutes for Biological Sciences Chinese Academy of Sciences May 01 2009

China

Principal Investigator

National Institute of Neurological Disorders and Stroke Nov 01 2006 - Apr 30 2009

United States

Research Fellow :: NINDS

Education History

Shanghai Institutes for Biological Sciences Sep 01 1996 - Jul 01 2001

China

PHD :: Shanghai Institute of Biochemistry

Nankai University Sep 01 1991 - Jul 01 1995

China

BSC :: Molecular biology

Publications

Run-Zhou Yang, Dian-Dian Wang, Sen-Miao Li, Pei-Pei Liu, Jian-Sheng Kang
Development and Application of a Mitochondrial Genetically Encoded Voltage Indicator in Narcosis. Neuroscience bulletin (2024)
Sen-Miao Li, Dian-Dian Wang, Dan-Hua Liu, Xiao-Yan Meng, Zhizhong Wang, Xitong Guo, Qian Liu, Pei-Pei Liu, Shu-Ang Li, Songwei Wang, Run-Zhou Yang, Yuming Xu, Longde Wang, Jian-Sheng Kang
Neurotransmitter accumulation and Parkinson's disease-like phenotype caused by anion channelrhodopsin opto-controlled astrocytic mitochondrial depolarization in substantia nigra pars compacta. MedComm 5 (6) (2024)
Sen-Miao Li, Dian-Dian Wang, Dan-Hua Liu, Xiao-Yan Meng, Zhizhong Wang, Xitong Guo, Qian Liu, Pei-Pei Liu, Shu-Ang Li, Songwei Wang, Run-Zhou Yang, Yuming Xu, Longde Wang, Jian-Sheng Kang
Neurotransmitter accumulation and Parkinson's disease-like phenotype caused by anion channelrhodopsin opto-controlled astrocytic mitochondrial depolarization in substantia nigra pars compacta. MedComm 5 (6) (2024)
Jian-Sheng Kang
Dietary restriction of amino acids for Cancer therapy. Nutrition & metabolism 17 (2020)
Jian-Sheng Kang, Pei-Pei Liu
Human herpesvirus 4 and adaptive immunity in Alzheimer's disease. Signal transduction and targeted therapy 5 (1) (2020)
Jian-Sheng Kang
Vitamin intervention for cytokine storm in the patients with coronavirus disease 2019. MedComm 1 (1) (2020)
Pei-Pei Liu, Yi Xie, Xiao-Yan Meng, Jian-Sheng Kang
History and progress of hypotheses and clinical trials for Alzheimer's disease. Signal transduction and targeted therapy 4 (2019)
Yi Xie, Pei-Pei Liu, Ya-Jun Lian, Hong-Bo Liu, Jian-Sheng Kang
The effect of selective serotonin reuptake inhibitors on cognitive function in patients with Alzheimer's disease and vascular dementia: focusing on fluoxetine with long follow-up periods. Signal transduction and targeted therapy 4 (1) (2019)
Pei-Pei Liu, Yi Xie, Xiao-Yan Meng, Jian-Sheng Kang
History and progress of hypotheses and clinical trials for Alzheimer's disease. Signal transduction and targeted therapy 4 (1) (2019)
Fang Li, Chun-Feng Liu, Yin-Zhen Xu, Yi-Lin Guo, Shu-Wen Xue, Xiang-Dong Kong, Hai-Bing Zhang, Yan Zhang, Jian-Sheng Kang
Neonatal lethality and recycling defect of transferrin receptor in mice with Syntaxin12/13 disruption. Protein & cell 10 (1) (2019)
Lulu Sun, Yuqing Wang, Jin Cen, Xiaolong Ma, Lei Cui, Zhixin Qiu, Zhengtao Zhang, Hong Li, Run-Zhou Yang, Chenhua Wang, Xiaotao Chen, Le Wang, Yao Ye, Haibin Zhang, Guoyu Pan, Jian-Sheng Kang, Yuan Ji, Yun-Wen Zheng, Shan Zheng, Lijian Hui
Modelling liver cancer initiation with organoids derived from directly reprogrammed human hepatocytes. Nature cell biology 21 (8) (2019)
Yi Xie, Pei-Pei Liu, Ya-Jun Lian, Hong-Bo Liu, Jian-Sheng Kang
The effect of selective serotonin reuptake inhibitors on cognitive function in patients with Alzheimer's disease and vascular dementia: focusing on fluoxetine with long follow-up periods. Signal transduction and targeted therapy 4 (2019)
Pei-Pei Liu, Yi Xie, Xiao-Yan Meng, Jian-Sheng Kang
Erratum: Author Correction: History and progress of hypotheses and clinical trials for Alzheimer's disease. Signal transduction and targeted therapy 4 (2019)
Tao-Rong Xie, Chun-Feng Liu, Jian-Sheng Kang
Sympathetic transmitters control thermogenic efficacy of brown adipocytes by modulating mitochondrial complex V. Signal transduction and targeted therapy 2 (2017)
Kun Fan, Xiaowen Wang, Jingwen Zhang, Romela Irene Ramos, Haibo Zhang, Chunjie Li, Dan Ye, Jian-Sheng Kang, Diego M Marzese, Dave S B Hoon, Wei Hua
Hypomethylation of CNTFRα is associated with proliferation and poor prognosis in lower grade gliomas. Scientific reports 7 (1) (2017)
Zhi-Dong Liu, Su Zhang, Jian-Jin Hao, Tao-Rong Xie, Jian-Sheng Kang
Cellular model of neuronal atrophy induced by DYNC1I1 deficiency reveals protective roles of RAS-RAF-MEK signaling. Protein & cell 7 (9) (2016)

Jian-Sheng Kang.css-eqlu8i{font-size:small;padding-left:4px;} (Jiansheng Kang)

Publication Activity (10 Years)

Top Topics

Top Venues

Jian-Sheng Kang (Jiansheng Kang)